Board approves results, INR 7 dividend and proposed 1:1 bonus

Results RestatedResults View source PDF Explain this filing

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹1545.00

prior close

₹1544.60

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.6%+2.2% vs market

Healthcare Service Provider peers, median of 22sector+0.0%+1.6% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Smallcap 250 and 1.6 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.2

10m

+1.8

15m

+1.9

30m

+2.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6-0.6+2.2+0.0+1.6

Next day

+5.1+0.1+5.0+0.0+5.1

+2.4-0.5+3.0+0.0+2.4

+0.8-2.0+2.8-2.3+3.1

+0.3-2.2+2.5-3.0+3.3

-0.2-2.3+2.0-0.4+0.2

-0.2-1.7+1.5-0.2+0.1

15d

+0.9-4.6+5.5-1.6+2.6

-1.0-3.7+2.7-5.8+4.8

-4.0-4.2+0.2-7.2+3.2

-7.8-10.9+3.2-14.2+6.4

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr Lal PathLabs approved unaudited results for the quarter and half-year ended 30 September 2025, with an unmodified auditor review. It declared a second interim dividend of INR 7 per share and proposed a 1:1 bonus of about 83.78 million shares. Standalone results were restated after a subsidiary transfer.

Likely market impact

Dividend supports returns; bonus adds no value. The 1:1 issue and up to 527,403 employee units can increase share count and dilute per-share figures.